News and Events
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
News and Events
Episode 10, “Revisiting Seamless 2/3 Trial for GLP-1 Agonist"
In this episode of "In the Interim..." we revisit the ground-breaking seamless phase 2/3 clinical trial for the GLP-1 agonist, dulaglutide—better known as Trulicity.
News and Events
Episode 9, “I-SPY 2 to GMB AGILE and Beyond"
In this episode of "In the Interim...," we sit down with Dr. Meredith Buxton to explore the evolution of platform trials from I-SPY 2 to GBM AGILE and Beyond.
News and Events
Today’s episode, “External Data in Clinical Trials"
In this episode of "In the Interim...," Scott Berry and Kert Viele navigate the nuanced debate surrounding the integration of external data in clinical trials.
News and Events
Episode 7, “Remembering Jimmie Savage"
In today's podcast episode, discover more about Jimmie Savage—the man who shaped Bayesian statistics and left an indelible mark on the field.
News and Events
Today’s Episode, “The Art and Slog of Innovating"
This week Dr. Michael Krams joins the podcast to discuss the art and slog of innovation in pharmaceutical companies and clinical trials.
News and Events
Episode 5 released today, "Religion, Politics, and Ordinal Outcomes"
In this latest episode of our podcast, Scott Berry discusses the controversial and vital topic of ordinal outcomes.
No results found.
There are no results with this criteria. Try changing your search.
